Skip Nav Destination
A comparison of allogeneic bone marrow transplantation, autologous bone marrow transplantation, and aggressive chemotherapy in children with acute myeloid leukemia in remission: a report from the Children's Cancer Group
Administration of herpes simplex–thymidine kinase–expressing donor T cells with a T-cell–depleted allogeneic marrow graft
V(D)J recombination defects in lymphocytes due toRAG mutations: severe immunodeficiency with a spectrum of clinical presentations
Rituximab (anti-CD20 monoclonal antibody) as single first-line therapy for patients with follicular lymphoma with a low tumor burden: clinical and molecular evaluation
Enhanced survival in Sandhoff disease mice receiving a combination of substrate deprivation therapy and bone marrow transplantation
Discontinuation of fucose therapy in LADII causes rapid loss of selectin ligands and rise of leukocyte counts
Issue Archive
January 1 2001
Table of Contents
INSIDE BLOOD
EDITORIALS
PLENARY PAPERS
REVIEW ARTICLES
CHEMOKINES
CLINICAL OBSERVATIONS, INTERVENTIONS, AND THERAPEUTIC TRIALS
A comparison of allogeneic bone marrow transplantation, autologous bone marrow transplantation, and aggressive chemotherapy in children with acute myeloid leukemia in remission: a report from the Children's Cancer Group
Clinical Trials & Observations
William G. Woods,Steven Neudorf,Stuart Gold,Jean Sanders,Jonathan D. Buckley,Dorothy R. Barnard,Kathryn Dusenbery,Joetta DeSwarte,Diane C. Arthur,Beverly J. Lange,Nathan L. Kobrinsky
Administration of herpes simplex–thymidine kinase–expressing donor T cells with a T-cell–depleted allogeneic marrow graft
Clinical Trials & Observations
Pierre Tiberghien,Christophe Ferrand,Bruno Lioure,Noël Milpied,Régis Angonin,Eric Deconinck,Jean-Marie Certoux,Eric Robinet,Philippe Saas,Bruno Petracca,Chris Juttner,Craig W. Reynolds,Dan L. Longo,Patrick Hervé,Jean-Yves Cahn
V(D)J recombination defects in lymphocytes due toRAG mutations: severe immunodeficiency with a spectrum of clinical presentations
Clinical Trials & Observations
Anna Villa,Cristina Sobacchi,Luigi D. Notarangelo,Fabio Bozzi,Mario Abinun,Tore G. Abrahamsen,Peter D. Arkwright,Michal Baniyash,Edward G. Brooks,Mary Ellen Conley,Patricia Cortes,Marzia Duse,Anders Fasth,Alexandra M. Filipovich,Anthony J. Infante,Alison Jones,Evelina Mazzolari,Susanna M. Muller,Srdjan Pasic,Gideon Rechavi,Maria Grazia Sacco,Sandro Santagata,Marlis L. Schroeder,Reinhard Seger,Dario Strina,Alberto Ugazio,Jouni Väliaho,Mauno Vihinen,Larry B. Vogler,Hans Ochs,Paolo Vezzoni,Wilhelm Friedrich,Klaus Schwarz
Rituximab (anti-CD20 monoclonal antibody) as single first-line therapy for patients with follicular lymphoma with a low tumor burden: clinical and molecular evaluation
Clinical Trials & Observations
Philippe Colombat,Gilles Salles,Nicole Brousse,Pitahey Eftekhari,Piere Soubeyran,Vincent Delwail,Eric Deconinck,Corinne Haı̈oun,Charles Foussard,Catherine Sebban,Astasia Stamatoullas,Noël Milpied,François Boué,Bruno Taillan,Pierre Lederlin,Albert Najman,Catherine Thièblemont,François Montestruc,Anne Mathieu-Boué,Aziz Benzohra,Philippe Solal-Céligny
GENE THERAPY
Systemic delivery of an adenoviral vector encoding canine factor VIII results in short-term phenotypic correction, inhibitor development, and biphasic liver toxicity in hemophilia A dogs
Angela M. Gallo-Penn,Pamela S. Shirley,Julie L. Andrews,Shawn Tinlin,Sandy Webster,Cherie Cameron,Christine Hough,Colleen Notley,David Lillicrap,Michael Kaleko,Sheila Connelly
HEMATOPOIESIS
HEMOSTASIS, THROMBOSIS, AND VASCULAR BIOLOGY
IMMUNOBIOLOGY
NEOPLASIA
PHAGOCYTES
RED CELLS
Lutheran blood group glycoprotein and its newly characterized mouse homologue specifically bind α5 chain-containing human laminin with high affinity
Stephen F. Parsons,Gloria Lee,Frances A. Spring,Thiebaut-Noel Willig,Luanne L. Peters,J. Aura Gimm,Michael J. A. Tanner,Narla Mohandas,David J. Anstee,Joel Anne Chasis
BRIEF REPORTS
Enhanced survival in Sandhoff disease mice receiving a combination of substrate deprivation therapy and bone marrow transplantation
Brief Report
Mylvaganam Jeyakumar,Francine Norflus,Cynthia J. Tifft,Mario Cortina-Borja,Terry D. Butters,Richard L. Proia,V. Hugh Perry,Raymond A. Dwek,Frances M. Platt
Discontinuation of fucose therapy in LADII causes rapid loss of selectin ligands and rise of leukocyte counts
Clinical Trials & Observations
Brief Report
CORRESPONDENCE
-
Cover Image
Cover Image
Advertisement
Email alerts
Advertisement